This fact sheet provides information on weight-loss dietary supplements*, including summaries of research on the safety and efficacy of several of the most commonly used ingredients in these products.
More than two-third of adults and almost one-third of children and adolescents in the United States are overweight or obese [1,
2]. Forty-five percent of overweight Americans and 67% of those who are obese are trying to lose weight [
3].
Health experts agree that making lifestyle changes—including
following a healthy eating pattern, reducing caloric intake, and
engaging in physical activity—is the basis for achieving long-term
weight loss [4-7].
But because making diet and lifestyle changes can be difficult, many
people turn to dietary supplements promoted for weight loss in the hope
that these products will help them more easily achieve their weight-loss
goals.
Use of weight-loss supplements in the United States is fairly common.
Approximately 15% of U.S. adults have used a weight-loss dietary
supplement at some point in their lives, with more women reporting use
(20.6%) than men (9.7%) [8].
Americans spend about $2 billion a year on weight-loss dietary
supplements in pill form (e.g., tablets, capsules, and softgels) [
9], and to lose weight is one of the top 20 reasons why people take dietary supplements [
10].
Dietary supplements promoted for weight loss encompass a wide variety
of products and come in a variety of forms, including capsules,
tablets, liquids, powders, and bars [11].
Manufacturers market these products with various claims, including that
these products reduce macronutrient absorption, appetite, body fat, and
weight and increase metabolism and thermogenesis. The average product
contains 10 different ingredients, but some contain as many as 96 [
11]. Common ingredients include botanicals (herbs and other plant components), dietary fiber, and minerals.
In its report on dietary supplements for weight loss, the U.S.
Government Accountability Office concluded that “little is known about
whether weight loss supplements are effective, but some supplements have
been associated with the potential for physical harm” [12].
Many weight-loss supplements are costly, and some of these products’
ingredients can interact or interfere with certain medications. So it is
important to consider what is known—and not known—about each ingredient
in any dietary supplement before using it.
People who are considering using weight-loss supplements should talk
with their health care provider to discuss these products’ potential
benefits and risks. This is especially important for those who have
medical conditions, including high blood pressure, diabetes, or heart
disease. Yet according to a large national survey, less than one-third
of U.S. adults who use weight-loss dietary supplements discuss this use
with a health care professional [8].
———————————
The U.S. Food and Drug Administration (FDA) regulates dietary
supplements promoted for weight loss in accordance with the Dietary
Supplement Health and Education Act of 1994 [13].
Like other dietary supplements, weight-loss supplements differ from
over-the-counter or prescription medications in that the FDA does not
classify them as drugs. Unlike drugs, dietary supplements do not require
premarket review or approval by the FDA. Supplement manufacturers are
responsible for determining that their products are safe and their label
claims are truthful and not misleading. However, manufacturers are not
required to provide that evidence to the FDA before marketing their
products. If the FDA finds a supplement to be unsafe, it may remove the
product from the market or ask the manufacturer to voluntarily recall
the product. The FDA and the Federal Trade Commission (FTC) may also
take regulatory actions against manufacturers that make unsubstantiated
weight-loss claims about their products. The FDA does not permit dietary
supplements to contain pharmaceutical ingredients, and manufacturers
may not promote these products to diagnose, treat, cure, or prevent any
disease [
13].
For more information about dietary supplement regulation, see the ODS publication, Dietary Supplements: What You Need to Know.
Weight-loss dietary supplements contain a wide variety of
ingredients. Not surprisingly, the amount of scientific information
available on these ingredients varies considerably. In some cases,
purported benefits are based on limited theoretical data or animal and
laboratory studies rather than human clinical trials. In other cases,
studies supporting a given ingredient’s use are small, of short
duration, and/or of poor quality, limiting the strength of the findings.
In almost all cases, additional research is needed to fully understand
the safety and/or efficacy of a particular ingredient [3].
Complicating the interpretation of many study results is the fact
that most weight-loss dietary supplements contain multiple ingredients,
making it difficult to isolate the effects of each ingredient and
predict the effects of the combination. Furthermore, dosages and amounts
of active components vary widely among weight-loss supplements, and a
product’s composition is not always fully described in published studies
[14].
Studies may also use different and sometimes inappropriate assessment
techniques to measure the effectiveness of a given treatment. All of
these factors can make it difficult to compare the results of one study
with another.
Table 1 briefly summarizes the findings discussed in more detail in
this fact sheet on the safety and efficacy of the most common
ingredients of weight-loss dietary supplements. These ingredients are
listed and discussed in the table and in the text in alphabetical order.
Dosage information is provided when such information is available.
However, because ingredients might not be standardized and many products
contain proprietary blends of ingredients, the active compounds and
their amounts might not be comparable among products [15].
Table 1: Common Ingredients in Weight-Loss Dietary Supplements*
Ingredient |
Proposed Mechanism of Action |
Evidence of Efficacy |
Evidence of Safety+ |
Bitter orange (synephrine) |
Increases energy expenditure and lipolysis, acts as a mild appetite suppressant |
Small clinical trials of poor methodological quality
Research findings: Possible effect on resting metabolic rate and energy expenditure; inconclusive effects on weight loss |
Some safety concerns reported
Reported adverse effects: Chest pain, anxiety, and increased blood pressure and heart rate |
Caffeine (as added caffeine or from guarana, kola nut, yerba mate, or other herbs) |
Stimulates central nervous system, increases thermogenesis and fat oxidation |
Short-term clinical trials of combination products
Research findings: Possible modest effect on body weight or decreased weight gain over time |
Safety concerns not usually reported at doses less than 400 mg/day for adults, significant safety concerns at higher doses
Reported adverse effects: Nervousness, jitteriness, vomiting, and tachycardia |
Calcium |
Increases lipolysis and fat accumulation, decreases fat absorption |
Several large clinical trials
Research findings: No effect on body weight, weight loss, or prevention of weight gain based on clinical trials |
No safety concerns reported at recommended intakes (1,000–1,200 mg/day for adults)
Reported adverse effects: Constipation, kidney stones, and interference with zinc and iron absorption at intakes above 2,000–2,500 mg for adults |
Chitosan |
Binds dietary fat in the digestive tract |
Small clinical trials, mostly of poor methodological quality
Research findings: Minimal effect on body weight |
Few safety concerns reported, could cause allergic reactions
Reported adverse effects: Flatulence, bloating, constipation, indigestion, nausea, and heartburn |
Chromium |
Increases lean muscle mass; promotes fat loss; and reduces food intake, hunger levels, and fat cravings |
Several clinical trials of varying methodological quality
Research findings: Minimal effect on body weight and body fat |
No safety concerns reported at recommended intakes (25–45 mcg/day for adults)
Reported adverse effects: Headache, watery stools, constipation, weakness, vertigo, nausea, vomiting, and urticaria (hives) |
Coleus forskohlii (forskolin) |
Enhances lipolysis and reduces appetite |
Few short-term clinical trials
Research findings: No effect on body weight |
No safety concerns reported
Reported adverse effects: None known |
Conjugated linoleic acid |
Promotes apoptosis in adipose tissue |
Several clinical trials
Research findings: Minimal effect on body weight and body fat |
Few safety concerns reported
Reported adverse effects: Abdominal discomfort and pain,
constipation, diarrhea, loose stools, dyspepsia, and (possibly) adverse
effects on blood lipid profiles |
Ephedra (ma huang, ephedrine) |
Stimulates central nervous system, increases thermogenesis, reduces appetite |
Several short-term clinical trials of good methodological quality, many of ephedra combined with caffeine
Research findings: Modest effect on short-term weight loss |
Significant safety concerns reported; banned as a dietary supplement ingredient
Reported adverse effects: Anxiety, mood changes, nausea, vomiting, hypertension, palpitation, stroke, seizures, heart attack, and death |
Fucoxanthin |
Increases energy expenditure and fatty acid oxidation, suppresses adipocyte differentiation and lipid accumulation |
Studied only in combination with pomegranate-seed oil in one trial in humans
Research findings: Insufficient research to draw firm conclusions |
No safety concerns reported but not rigorously studied
Reported adverse effects: None known |
Garcinia cambogia (hydroxycitric acid) |
Inhibits lipogenesis, suppresses food intake |
Several short-term clinical trials of varying methodological quality
Research findings: Little to no effect on body weight |
Few safety concerns reported
Reported adverse effects: Headache, nausea, upper respiratory tract symptoms, and gastrointestinal symptoms |
Glucomannan |
Increases feelings of satiety and fullness, prolongs gastric emptying time |
Several clinical trials of varying methodological quality, mostly focused on effects on lipid and blood glucose levels
Research findings: Little to no effect on body weight |
Significant safety concerns reported with tablet
forms, which might cause esophageal obstructions, but few safety
concerns with other forms
Reported adverse effects: Loose stools, flatulence, diarrhea, constipation, and abdominal discomfort |
Green coffee bean extract (Coffea aribica, Coffea canephora, Coffea robusta) |
Inhibits fat accumulation, modulates glucose metabolism |
Few clinical trials, all of poor methodological quality
Research findings: Possible modest effect on body weight |
Few safety concerns reported but not rigorously studied; contains caffeine
Reported adverse effects: Headache and urinary tract infections |
Green tea (Camellia sinensis) and green tea extract |
Increases energy expenditure and fat oxidation, reduces lipogenesis and fat absorption |
Several clinical trials of good methodological quality on green tea catechins with and without caffeine
Research findings: Possible modest effect on body weight |
No safety concerns reported when used as a beverage, contains caffeine; some safety concerns reported for green tea extract
Reported adverse effects (for green tea extract): Constipation, abdominal discomfort, nausea, increased blood pressure, liver damage |
Guar gum |
Acts as bulking agent in gut, delays gastric emptying, increases feelings of satiety |
Several clinical trials of good methodological quality
Research findings: No effect on body weight |
Few safety concerns reported with currently available formulations
Reported adverse effects: Abdominal pain, flatulence, diarrhea, nausea, and cramps |
Hoodia (Hoodia gordonii) |
Suppresses appetite, reduces food intake |
Very little published research in humans
Research findings: No effect on energy intake or body weight based on results from one study |
Some safety concerns reported, increases heart rate and blood pressure
Reported adverse effects: Headache, dizziness, nausea, and vomiting |
Pyruvate |
Increases lipolysis and energy expenditure |
Few clinical trials of weak methodological quality
Research findings: Possible minimal effect on body weight and body fat |
Few safety concerns reported
Reported adverse effects: Diarrhea, gas, bloating, and (possibly) decreased high-density lipoprotein levels |
Raspberry ketone |
Alters lipid metabolism |
Studied only in combination with other ingredients
Research findings: Insufficient research to draw firm conclusions |
No safety concerns reported but not rigorously studied
Reported adverse effects: None known |
White kidney bean (Phaseolus vulgaris) |
Interferes with breakdown and absorption of carbohydrates by acting as a “starch blocker” |
Several clinical trials of varying methodological quality
Research findings: Possible modest effect on body weight and body fat |
Few safety concerns reported
Reported adverse effects: Headache, soft stools, flatulence, and constipation |
Yohimbe (Pausinystalia yohimbe, yohimbine) |
Has hyperadrenergic effects |
Very little research on yohimbe for weight-loss
Research findings: No effect on body weight; insufficient research to draw firm conclusions |
Significant safety concerns reported
Reported adverse effects: Headache, anxiety, agitation, hypertension, and tachycardia |
* References to support statements in Table 1 are provided in subsequent text.
+Listed in order of severity, with the most severe reported side effects listed last.
Bitter orange (synephrine)
Bitter orange is the common name for the botanical Citrus aurantium. This plant is a source of p-synephrine (often referred to simply as synephrine) and other protoalkaloids [16-19].
As alpha-adrenergic agonists, synephrine alkaloids can mimic the action
of epinephrine and norepinephrine. However, the extent to which bitter
orange and synephrine cause similar cardiovascular and
central-nervous-system effects to epinephrine and norepinephrine (e.g.,
increased heart rate and blood pressure) is not clear [
16-18].
Studies suggest that bitter orange increases energy expenditure and lipolysis and that it acts as a mild appetite suppressant [16,
20]. After the FDA banned the use of ephedrine alkaloids in dietary supplements in 2004 (see section on ephedra
[ma huang]), manufacturers replaced ephedra with bitter orange in many
products; thus, bitter orange became known as an “ephedra substitute” [
21]. Although synephrine has some structural similarities to ephedrine, it has different pharmacological properties [
18,
20].
Efficacy: Several small human studies have examined whether bitter orange is effective for weight loss [20].
Interpreting the results of these studies is complicated by the fact
that bitter orange is almost always combined with other ingredients in
weight-loss supplements.
In one study, 20 healthy overweight adults (body mass index [BMI]
>25) took a product containing 975 mg bitter orange extract (6%
synephrine alkaloids), 528 mg caffeine, and 900 mg St. John’s wort; a
placebo; or nothing (control) each day for 6 weeks [22].
All participants also took part in a circuit-training exercise program
and were counseled to follow an 1,800 kcal/day diet. At the end of the
study, participants taking the combination bitter orange product had a
significantly greater reduction in percent body fat and fat mass and a
greater increase in basal metabolic rate than those in the placebo and
control groups. Participants in all groups lost weight, but the authors
did not report whether the mean reduction in body weight in the
treatment group (1.4 kg) was significantly greater than that in the
placebo (0.9 kg) or control groups (0.4 kg) [
23].
In another study, 8 healthy overweight or obese people (BMI 25–40)
received counseling to follow a 1,200–1,500 kcal/day diet and were
randomized to take either an herbal supplement containing bitter orange
(18 mg synephrine/day) and other ingredients, including guarana extract
as a source of caffeine (396 mg caffeine/day), or placebo [24].
The peak rise in resting metabolic rate at baseline was significantly
higher in participants taking the herbal supplement than those in the
placebo group, but the difference was not significant at the end of the
8-week study. The herbal supplement also produced a significant
increase
in mean body weight (1.13 kg) compared with placebo (0.09 kg) at the
end of the study. However, this increase in body weight did not
significantly affect body fat and lean tissue levels or waist
circumference. The authors noted that the weight gain might have
occurred by chance because the trial was insufficiently powered to
detect this small difference.
The authors of a 2012 review of 23 small human clinical studies
involving a total of 360 participants concluded that synephrine
increases resting metabolic rate and energy expenditure [20].
The authors of an earlier review of animal studies, clinical trials,
physiologic studies, and case reports concluded that synephrine
alkaloids have a “suggestion of some benefit to weight loss,” but the
available data are very limited and cannot be considered conclusive [
16].
The authors of both reviews stated that longer-term clinical trials
with rigorous designs and large samples are needed to determine the
value of bitter orange for weight loss.
Safety: Products containing bitter orange have significant
safety concerns. Reported adverse effects include chest pain, anxiety,
ventricular fibrillation, ischemic stroke, myocardial infarction, and
death [25].
However, many of the products with these effects contained multiple
herbal ingredients, and the role of bitter orange in these adverse
effects cannot be determined. Some studies indicate that bitter orange
and synephrine—as bitter orange extract or pure synephrine–—raise blood
pressure and heart rate in humans and rats, but other studies show that
they do not have these effects [
16-18,
22,
26-29]. Thus, some researchers have suggested that synephrine might not act directly as a cardiovascular stimulant [
18,
27,
29].
Instead, caffeine, other stimulants in multi-component formulations,
other constituents of bitter orange or adulterants, such as m-synephrine
(which is not naturally present in bitter orange), might be responsible
for its observed effects.
Caffeine, including caffeine from guarana, kola nut, yerba mate, or other herbs
Caffeine (either added to a weight-loss supplement or as an herbal source that naturally contains caffeine, such as guarana (Paullinia cupana), kola (or cola) nut (Cola nitida), and yerba mate (Ilex paraguariensis),
is commonly found in dietary supplements promoted for weight loss.
Green tea and other forms of tea also contain caffeine (see section on green tea).
Some weight-loss supplement labels do not declare the amount of
caffeine in the product, only the herbal ingredients. As a result,
consumers might not be aware that the presence of certain herbs means
that a product contains caffeine and possibly other stimulants [30].
Caffeine is a methylxanthine that stimulates the central nervous
system, heart, and skeletal muscles. It also increases gastric and
colonic activity and acts as a diuretic [31,
32]. Its half-life is about 6 hours. Caffeine increases thermogenesis in a linear, dose-dependent fashion in humans [
33].
A 100 mg dose of caffeine, for example, increased energy expenditure by
a mean of 9.2 kcal/hr more than placebo in healthy humans. Caffeine
might also contribute to weight loss by increasing fat oxidation through
sympathetic activation of the central nervous system and by acting as a
diuretic [
30,
33]. Habitual use of caffeine however, may diminish these effects due to the development of caffeine tolerance [
30,
32].
Efficacy: Clinical trials examining the effects of caffeine on
weight loss have all been short term and have used combination
products. In one study, 167 overweight or obese participants (BMI 25–40)
took a supplement containing ma huang (90 mg/day ephedrine) and kola
nut (192 mg/day caffeine) or placebo [34].
Participants were counseled to eat a normal diet except for limiting
dietary fat to 30% of calories and to exercise moderately. After 6
months, those in the treatment group lost significantly more weight
(mean weight loss 5.3 kg) than those in the placebo group (2.6 kg) and
had significantly greater body fat reduction.
In another study, 47 overweight adults (BMI 26–30) were randomized to
take a combination product containing 336 mg yerba mate (1-1.5%
caffeine), 285 mg guarana (3–6% caffeine), and 108 mg damiana (a
botanical extract that contains ethereal oils, resins, and tannins but
not caffeine) or placebo 15 minutes before each main meal for 45 days
while maintaining their normal eating habits [35].
At the end of the study, participants taking the herbal product lost a
mean of 5.1 kg compared to 0.3 kg for those taking the placebo.
Data from a 12-year prospective observational study provide some
insight into the long-term association between caffeine intake and body
weight [36].
In this study, researchers followed 18,417 healthy men and 39,740
healthy women who were enrolled in either the Nurses’ Health Study or
the Health Professionals Follow-Up Study. On average, participants
gained some weight during the study, but men who increased their
caffeine intake during the 12 years of follow-up gained a mean of 0.43
kg less than those who decreased their caffeine consumption. For women,
the corresponding mean difference in weight gain was 0.35 kg less.
Safety: For healthy adults, the FDA states that 400 mg/day caffeine is “not generally associated with dangerous, negative effects” [37]. For comparison, an 8- ounce cup of brewed coffee contains about 85 mg caffeine [
38].
The FDA has not set a safe level of intake for children, but the
American Academy of Pediatrics discourages children and adolescents from
consuming caffeine and other stimulants [
37].
Caffeine can cause sleep disturbances and feelings of nervousness,
jitteriness, and shakiness. Caffeine can be toxic when used in high
doses, causing nausea, vomiting, tachycardia, seizures, and cerebral
edema [31].
Toxic effects have been reported with doses of 15 mg/kg (about 1,000 mg
for a 150-lb adult) and fatalities with doses above 150 mg/kg (about
10,000 mg for a 150-lb adult). Combining caffeine with other stimulants,
such as bitter orange and ephedrine, can potentiate these adverse
effects.
Calcium
Calcium is an essential mineral that is stored in the bones and
teeth, where it supports their structure and function. Calcium is
required for vascular contraction and vasodilation, muscle function,
nerve transmission, intracellular signaling, and hormonal secretion [39].
The Recommended Dietary Allowance (average daily level of intake
sufficient to meet the nutrient needs of 97%–98% of healthy individuals)
for calcium ranges from 1,000 to 1,300 mg/day for children and adults
aged 4 years and older.
Several studies have correlated higher calcium intakes with lower body weight or less weight gain over time [40-43].
Two explanations have been proposed. First, high calcium intakes might
reduce calcium concentrations in fat cells by decreasing the production
of parathyroid hormone and the active form of vitamin D. Decreased
intracellular calcium concentrations, in turn, might increase fat
breakdown and discourage fat accumulation in these cells [
42].
Second, calcium from food or supplements might bind to small amounts of
dietary fat in the digestive tract and prevent absorption of this fat [
42,
44,
45].
Dairy products, in particular, might contain additional components that
have even greater effects on body weight than their calcium content
alone would suggest [
43,
46-50].
Efficacy: The results from clinical trials examining the
effects of calcium on body weight have been largely negative. For
example, supplementation with 1,500 mg/day calcium (from calcium
carbonate) was investigated in 340 overweight or obese adults (BMI ≥25)
with mean baseline calcium intakes of 878 mg/day (treatment group) and
887 mg/day (placebo group) [51].
Compared to placebo, calcium supplementation for 2 years had no
clinically significant effects on weight. Three reviews of published
studies on the effects of calcium from supplements or dairy products on
weight management produced similar conclusions [
52-54].
The authors of a 2006 meta-analysis of 13 randomized controlled trials
concluded that neither calcium supplementation nor increased dairy
product consumption has a statistically significant effect on weight
reduction [
54].
A 2009 evidence report from the Agency for Healthcare Research and
Quality showed that, overall, clinical trial results do not support an
effect of calcium supplementation on weight [
52].
Also, a 2012 meta-analysis of 29 randomized controlled trials found no
benefit of increased consumption of dairy products on body weight and
fat loss in long-term studies [
53].
Overall, the results from clinical trials do not support a link between
higher calcium intakes and lower body weight, prevention of weight
gain, or weight loss.
Safety: The Tolerable Upper Intake Level (UL; maximum daily
intake unlikely to cause adverse health effects) for calcium established
by the Institute of Medicine of the National Academies is 2,500 mg/day
for adults aged 19–50 years and 2,000 mg for adults aged 51 and older [39].
High intakes of calcium can cause constipation and might interfere with
the absorption of iron and zinc, although this effect is not well
established. High intakes of calcium from supplements, but not foods,
have been associated with an increased risk of kidney stones [
39,
55-57].
Chitosan
Chitosan is a polysaccharide derived from the exoskeletons of
crustaceans. It is purported to promote weight loss by binding dietary
fat in the digestive tract [30]. However, the amount of fat that chitosan binds is clinically insignificant [
58].
Efficacy: In a small study, 12 healthy men and 12 healthy
women (BMI 20–36) followed the same diet for 12 days (five meals per day
with 38% of energy from fat). Chitosan capsules taken before meals
(total of 2.5 g/day) slightly increased fecal fat excretion in the men
compared to the control group [58].
However, the amount of fat that the chitosan trapped would result in a
loss of only 1 pound of body fat over about 7 months. Chitosan had no
significant effect on fecal fat excretion in the women compared to the
control group.
One clinical trial randomly assigned 59 overweight or obese women
(BMI 27–40) to receive either chitosan (3 g/day divided between the two
largest meals) or placebo for 8 weeks while continuing their normal
dietary and exercise habits [59].
At the end of the study, those in the treatment group lost a mean of 1
kg body weight compared to a mean weight gain of 1.5 kg in the placebo
group. In a 28-day trial, chitosan (2 g/day divided into two equal
doses) failed to reduce body weight compared to placebo in 28 overweight
women and 6 overweight men who maintained their normal diet during the
study [
60].
The authors of a Cochrane review that included 13 trials examining the
effect of chitosan on body weight found that chitosan, when taken for 4
weeks to 6 months, reduced body weight by a mean of 1.7 kg compared with
placebo [
61].
They concluded that chitosan appears to be more effective than placebo
for short-term weight loss, but most studies have been of poor quality.
The authors noted that results from high-quality trials indicate that
chitosan has minimal effects on body weight and these effects are
probably clinically insignificant.
Safety: The adverse effects of chitosan are minor and
primarily affect the gastrointestinal tract. These effects include
flatulence, bloating, mild nausea, constipation, indigestion, and
heartburn [59-61].
Because chitosan is derived from shellfish, people who are allergic to
shellfish could theoretically be allergic to chitosan [
62].
Chromium
Chromium in its trivalent form (chromium III) is an essential trace
mineral that potentiates the action of insulin. The Institute of
Medicine of the National Academies has established an Adequate Intake
for chromium of 20–35 mcg/day for non-pregnant, non-lactating adults [63].
Dietary supplements commonly contain chromium in the form of chromium
picolinate, which consists of chromium and picolinic acid, although they
might also contain other forms, including chromium nicotinate and
chromium yeast [
64]. Poor chromium status may contribute to impaired glucose tolerance and type 2 diabetes [
63].
Researchers have hypothesized that chromium supplements increase lean
muscle mass and promote fat loss, but study results have been equivocal [
30,
65]. Some research indicates that these supplements might also reduce food intake, hunger levels, and fat cravings [
66], although data on these effects are sparse.
Efficacy: Several studies have evaluated the effects of
chromium supplements, usually in the form of chromium picolinate, on
weight loss. A 2013 Cochrane review analyzed the results from 9
randomized controlled trials of chromium picolinate supplements in a
total of 622 overweight or obese participants (BMI ≥25) [65].
Trial durations ranged from 8 weeks to 6 months, and doses of chromium
picolinate were 200 to 1,000 mcg/day. Six of the trials included
resistance or weight training, and three did not. The authors found that
chromium picolinate supplementation reduced body weight by 1.1 kg more
than placebo, but the amount of weight loss did not correlate with the
dose of chromium picolinate. The authors stated that the effect is of
“debatable clinical relevance” and the overall quality of the evidence
is low.
Also in 2013, a systematic review and meta-analysis of 11 randomized,
controlled trials (including most of the trials evaluated in the
Cochrane review) examined the effects of chromium supplementation in a
total of 866 overweight or obese individuals [64].
The authors concluded that chromium reduces body weight by 0.5 kg and
percent body fat by 0.46% when taken at daily doses of 137 to 1,000 mcg
for 8 to 26 weeks. Like the authors of the Cochrane review, these
authors noted that the effect is small and of “uncertain” clinical
relevance. Similar findings were reported from an earlier meta-analysis
of 12 trials [
67].
Safety: Trivalent chromium appears to be well tolerated.
Adverse effects from clinical trials include watery stools, headache,
weakness, nausea, vomiting, constipation, vertigo, and urticaria (hives)
[64,
65]. Chromium does not have an established UL because few serious adverse effects have been linked to high chromium intakes [
63]. Hexavalent chromium (chromium IV) is toxic and is not found in food or dietary supplements.
Cola (or kola) nut (see section on caffeine above)
Coleus forskohlii (forskolin)
Forskolin is a compound isolated from the roots of Coleus forskohlii,
a plant that grows in subtropical areas, such as India and Thailand.
Forskolin is purported to promote weight loss by enhancing lipolysis and
reducing appetite [68,
69].
Efficacy: Although animal studies indicate that forskolin reduces food intake [68],
research in humans is very limited and inconclusive. In a small,
randomized, double- blind trial, 19 overweight or obese females (BMI
25–35) aged 18–40 years received either forskolin (250 mg of 10%
forskolin extract [ForsLean&supTM;] taken before breakfast and
dinner for a total daily dose of 500 mg) or placebo while continuing
their usual diet for 12 weeks [
70].
Compared to placebo, forskolin had no effect on body weight, appetite,
caloric intake, or macronutrient intake. The same forskolin product and
dose were evaluated in another 12-week, randomized, double-blind trial
involving 30 overweight men (BMI ≥26) [
69].
In this study, forskolin did not affect body weight, but it did
significantly decrease mean body fat by 4.14% compared with placebo
(0.96%).
Safety: No significant adverse events were reported in the two 12-week trials detailed above [69,
70],
but forskolin has not been evaluated in longer-term trials. Additional
research is needed to better understand its safety and side effects for
both short- and long-term use.
Conjugated linoleic acid
Conjugated linoleic acid (CLA) is a derivative of linoleic acid that
is present mainly in dairy products and beef. CLA exists in several
different isomeric forms, including c9t11 -CLA and t10c12-CLA, and is
available in dietary supplements as a triacylglycerol or as a free fatty
acid [71]. Researchers have suggested that CLA enhances weight loss by promoting apoptosis in adipose tissue [
72].
Efficacy: Although CLA appears to reduce body fat mass in animals [72], results from human studies suggest that its effects are small and of questionable clinical relevance [
73].
One double-blind, placebo-controlled trial evaluated the effects of CLA
supplementation (as a 50:50 mixture of c9t11-CLA and t10c12-CLA) in 180
overweight male and female volunteers (BMI 25–30) consuming an ad
libitum diet [
71].
Participants received CLA as a free fatty acid (3.6 g CLA isomers), CLA
as a triacylglycerol (3.4 g CLA isomers), or placebo daily for 1 year.
At the end of the study, supplementation with CLA as a free fatty acid
and as a triacylglycerol significantly reduced body fat mass by a mean
of 6.9% and 8.7%, respectively, compared with placebo. Supplementation
with CLA as a free fatty acid (but not as a triacylglycerol) also
increased lean body mass compared with placebo.
In another double-blind crossover trial, daily supplementation with
CLA oil (6.4 g CLA isomers—approximately equal amounts of c9t11-CLA and
t10c12-CLA) for 16 weeks significantly reduced BMI and total adipose
mass compared with safflower oil in 35 obese postmenopausal women (BMI
>30) with type 2 diabetes [74].
The authors of a systematic review and meta-analysis of 7 randomized
controlled trials concluded that taking CLA for 6–12 months reduces body
weight by a mean of 0.7 kg and body fat by a mean of 1.33 kg compared
to placebo [73]. However, the authors noted that the “magnitude of these effects is small, and the clinical relevance is uncertain.”
Safety: CLA appears to be well tolerated. Most reported
adverse effects are minor, consisting mainly of gastrointestinal
disturbances, such as abdominal discomfort and pain, constipation,
diarrhea, loose stools, and dyspepsia [3,
71,
73,
75,
76].
CLA might adversely affect lipid profiles, although results from
studies are inconsistent. Some research indicates that CLA has no major
effect on lipid profiles, but other research shows that certain CLA
isomers might decrease high-density lipoprotein (HDL) cholesterol and
increase lipoprotein(a) levels [71,
76-80].
The CLA isomer t10c12-CLA has also been reported to increase insulin
resistance and glycemia in obese men with metabolic syndrome [
80].
Ephedra (ma huang)
Ephedra (also known as ma huang), a plant native to China, is the common name for three main species: Ephedra sinica, Ephedra equisentina, and Ephedra intermedia [81].
The active compounds, which are in the plant’s stem and account for
about 1.32% of the plant’s weight, are the alkaloids ephedrine,
pseudoephedrine, norephedrine, and norpseudoephedrine [
82,
83].
In the 1990s, ephedra—frequently combined with caffeine—was a popular
ingredient in dietary supplements sold for weight loss and enhanced
athletic performance. The FDA no longer permits the use of ephedra in
dietary supplements because of safety concerns that are detailed below,
but information is provided here due to continued interest in this
ingredient.
Efficacy: Ephedrine acts as a stimulant in the central nervous system [84,
85]. It also may increase thermogenesis and act as an appetite suppressant [
86].
The authors of a meta-analysis that included 20 clinical trials
concluded that ephedrine and ephedra are modestly effective for
short-term weight loss (6 months or less), but no studies have assessed
their long-term effects [
87].
Safety: While ephedra was available as a dietary supplement
ingredient in the United States, its use with or without caffeine was
associated with numerous reported adverse effects, including nausea,
vomiting, psychiatric symptoms (such as anxiety and mood change),
hypertension, palpitations, stroke, seizures, heart attack, and death [87,
88].
Although these reported adverse effects could not be linked with
certainty to the use of ephedra-containing dietary supplements, the FDA
deemed the safety concerns serious enough to prohibit the sale of
dietary supplements containing ephedrine alkaloids in 2004 [
89].
As a result of this ruling, manufacturers are no longer permitted to
sell dietary supplements containing ephedrine alkaloids in the United
States.
Fucoxanthin
Fucoxanthin is a carotenoid that is found in brown seaweed and other
algae. Results from laboratory and animal studies suggest that
fucoxanthin might promote weight loss by increasing resting energy
expenditure and fatty acid oxidation as well as by suppressing adipocyte
differentiation and lipid accumulation [90,
91].
Efficacy: Only one human clinical trial has been conducted on
the possible weight-loss effects of fucoxanthin. This 16-week trial used
Xanthigen®, a dietary supplement containing brown seaweed extract and
pomegranate-seed oil [92].
In one arm of this study, 110 obese (BMI >30) premenopausal women,
72 of whom had non-alcoholic fatty liver disease (NAFLD), received
either a placebo or Xanthigen® three times a day before meals for a
total daily dose of 2.4 mg fucoxanthin and 300 mg pomegranate-seed oil.
Participants followed a controlled diet that limited total energy intake
to 1,800 kcal/day. Compared to the placebo group, those receiving
Xanthigen® lost significantly more body weight by the end of the trial
(mean loss of 6.9 kg vs. 1.4 kg for placebo in participants with NAFLD;
mean loss of 6.3 kg vs. 1.4 kg for placebo in those without NAFLD).
Because this is the only clinical trial on a dietary supplement
containing fucoxanthin, additional research is needed to understand its
potential effects on body weight.
Safety: The safety of fucoxanthin has not been thoroughly
evaluated in humans. Although participants using Xanthigen® in the
clinical trial described above reported no adverse effects [92], further investigation of the safety and potential side effects of fucoxanthin at various levels of intake is required.
Garcinia cambogia (hydroxycitric acid)
Garcinia cambogia is a fruit-bearing tree that grows throughout Asia, Africa, and the Polynesian islands [93].
The pulp and rind of its fruit contain high amounts of hydroxycitric
acid (HCA), a compound that some researchers believe inhibits
lipogenesis, increases hepatic glycogen synthesis, suppresses food
intake, and reduces weight gain [
6,
15,
72,
93,
94].
Efficacy: Studies in rats have found that Garcinia cambogia suppresses food intake and inhibits weight gain [3]. In humans, however, the evidence on whether
Garcinia cambogia or HCA is effective for weight loss is conflicting, and any effects it has appear to be small [
6,
72,
93-95].
In one randomized, placebo-controlled trial, 89 mildly overweight
women (weighing 10–50 lb more than ideal body weight) received Garcinia cambogia
(800 mg, 30–60 minutes before meals for a total daily dose of 2.4 g/day
[1.2 g HCA]) or placebo and followed a 1,200 kcal diet for 12 weeks [96]. Women receiving
Garcinia cambogia lost significantly more weight (3.7 kg) than those receiving placebo (2.4 kg). However,
Garcinia cambogia
did not alter appetite, and the study produced no evidence that the
supplement affected feelings of satiety. In another double-blind,
placebo-controlled trial, 135 overweight men and women (BMI 27–38)
received either
Garcinia cambogia (1,000 mg, 30 minutes before
each meal for a total daily dose of 3,000 mg/day [1,500 mg HCA]) or
placebo and followed a high-fiber, low-energy diet for 12 weeks [
97].
Participants in both groups lost weight, but the between-group
weight-loss differences were not statistically significant. HCA also had
no effect on body fat loss.
A 2011 review and meta-analysis of 12 randomized, controlled trials
with a total of 706 participants examined the effects of HCA on weight
loss [95].
The findings from 9 of the trials (those that had data suitable for
statistical pooling) indicate that when taken for 2–12 weeks, HCA
reduces body weight in the short term by a mean of 0.88 kg compared to
placebo. However, the authors noted that when they considered only
rigorously designed trials, the effect was no longer statistically
significant. Therefore, the effect of HCA on body weight remains
uncertain. The authors of a 2013 review of
Garcinia cambogia/HCA reached similar conclusions, noting that whether
Garcinia cambogia/HCA is effective for obesity “remains to be proven in larger-scale and longer-term clinical trials” [
98].
Safety: The reported adverse effects of Garcinia cambogia and HCA are generally mild and include headache, nausea, upper respiratory tract symptoms, and gastrointestinal symptoms [93,
95,
97]. Cases of liver toxicity have been reported in people taking products containing
Garcinia cambogia, other botanical ingredients, and minerals [
32]. However, it is unclear whether this toxicity can be attributed to
Garcinia cambogia. Because all clinical trials of
Garcinia cambogia and HCA have been short, its long-term safety is unknown.
Glucomannan
Glucomannan is a soluble dietary fiber derived from konjac root (Amorphophallus konjac).
Some researchers believe that, like guar gum, glucomannan absorbs water
in the gastrointestinal tract, thereby increasing feelings of satiety
and fullness and prolonging gastric emptying [99,
100].
Efficacy: Glucomannan appears to have beneficial effects on blood lipids and glucose levels [100],
but its effects on weight loss are inconsistent. In one study conducted
in Italy, 2 g/day glucomannan (in 2 divided doses) in 60 obese children
(mean age 11.2 years) for 2 months did not significantly affect weight
loss compared to placebo [
101].
In a small study conducted in the United States, 20 obese women
(weighing ≥20% more than ideal body weight) consumed 3 g/day glucomannan
(1 g before each meal) or placebo for 8 weeks [
102].
At the end of the study, glucomannan produced significantly greater
weight loss (mean loss of 2.5 kg) than placebo (mean gain of 0.7 kg). In
another study conducted in the United States, supplementation with
glucomannan (3.9 g/day) for 4 weeks in 63 healthy men did not
significantly affect body weight compared with placebo [
103].
The authors of a 2015 systematic review of six randomized controlled
trials with a total of 293 participants concluded that 1.24 to 3.99
g/day glucomannan for up to 12 weeks does not have a significant effect
on body weight compared to placebo [104,
105].
Similarly, a 2014 meta-analysis of eight trials that included 301
participants found that glucomannan did not significantly affect weight
loss compared to placebo [
106].
The authors of an older meta-analysis of 14 studies designed primarily
to investigate glucomannan’s effect on lipid and blood glucose levels
concluded that 1.2 to 15.1 g/day glucomannan reduces body weight by a
small but statistically significant amount (mean loss 0.79 kg more than
placebo) over about 5 weeks [
100].
Safety: Little is known about the long-term safety of
glucomannan. Glucomannan appears to be well tolerated for short-term
use, with minor adverse effects including loose stools, flatulence,
diarrhea, constipation, and abdominal discomfort [100,
104,
106].
The use of tablet forms of glucomannan was reported to be associated
with seven cases of esophageal obstruction in 1984–1985 in Australia [
99].
Caution is therefore warranted when these forms of glucomannan are
used. Powdered or capsule forms have not been associated with this
effect [
107].
Green coffee bean extract (Coffea aribica, Coffea canephora, Coffea robusta)
Coffee beans (Coffea aribica, Coffea canephora, Coffea robusta)
are green until they are roasted. Compared to roasted beans, green
coffee beans have higher levels of chlorogenic acid. Green coffee
extract, likely due to its chlorogenic acid content, has been shown in
mice and humans to inhibit fat accumulation and modulate glucose
metabolism [108], perhaps by reducing the absorption of glucose in the gut [
109]. Green coffee beans also contain caffeine (see section on caffeine above) [
110].
Efficacy: Only a few clinical trials have examined the effects
of green coffee bean on weight loss, and all are of poor methodological
quality. Onakpoya and colleagues conducted a meta-analysis of three
trials in which overweight participants received either 180 or 200
mg/day green coffee extract for 4 to 12 weeks [109].
The researchers concluded that green coffee extract has a moderate but
significant effect on body weight (mean weight loss of 2.47 kg more than
placebo), but they noted that the methodological quality of all studies
included in the meta-analysis was poor.
Another small clinical trial claimed to show a benefit of green coffee extract for weight loss [111], but it was strongly criticized by the FTC for having several critical flaws in the study design [
112,
113]. Two of the three study authors subsequently retracted the journal publication.
Safety: Green coffee extract appears to be well tolerated, but
its safety has not been rigorously studied. Reported adverse effects
include headaches and urinary tract infections [109].
The caffeine in green coffee beans acts as a stimulant and can cause
adverse effects, depending on the dose and whether it is combined with
other stimulants (see section on caffeine above).
Green tea (Camellia sinensis) and green tea extract
Green tea (Camellia sinensis) is a popular beverage consumed worldwide that has several purported health benefits [114].
Green tea is present in some dietary supplements, frequently in the
form of green tea extract. The active components of green tea that are
associated with weight loss are caffeine (see section on caffeine above) and catechins, primarily epigallocatechin gallate (EGCG), which is a flavonoid [
30,
114]. A typical brewed cup of green tea has about 240–320 mg catechins [
114]
and 45 mg caffeine. Experts have suggested that green tea and its
components might reduce body weight by increasing energy expenditure and
fat oxidation, reducing lipogenesis, and decreasing fat absorption [
30,
115,
116].
The authors of a meta-analysis of 6 randomized controlled trials with
a total of 98 participants found that caffeine alone or in combination
with catechins significantly increases energy expenditure in a
dose-dependent fashion compared with placebo [115].
This effect might be important for maintaining weight loss by helping
to counteract the decrease in metabolic rate that can occur during
weight loss. Catechins combined with caffeine also significantly
increase fat oxidation, but caffeine alone does not. Other human
research indicates that EGCG alone does not increase resting metabolic
rate, fat oxidation, or the thermic effect of feeding (the increase in
metabolic rate associated with the digestion and absorption of food) [
117,
118].Taken together, these findings suggest that green tea catechins and caffeine might act synergistically [
30,
115,
116].
Efficacy: Several human studies have examined the effects of
green tea catechins on weight loss and weight maintenance. A 2012
Cochrane review analyzed the results from 14 randomized controlled
trials of green tea preparations in a total of 1,562 overweight or obese
participants [119].
The trials lasted from 12 to 13 weeks, and doses of green tea catechins
ranged from 141 to 1,207 mg. Green tea supplementation reduced body
weight by a mean of 0.95 kg more than placebo. However, when the authors
analyzed the six studies that were conducted outside of Japan (where
study methodologies were less heterogeneous than in the Japanese
studies), they found no statistically significant difference in weight
loss for green tea compared to placebo.
Another systematic review and meta-analysis included 15 randomized
controlled trials, 6 of which examined the effects of caffeine (39–83
mg/day) with and without green tea catechins (576–690 mg/day) on
anthropometric measurements. The authors reported that green tea
catechins combined with caffeine over a median of 12 weeks modestly yet
significantly reduced body weight by a mean of 1.38 kg and waist
circumference by a mean of 1.93 cm compared with caffeine alone [120].
Only two studies in this meta-analysis examined the effects of green
tea catechins alone. Their results suggest that green tea catechins
alone do not affect body weight or other anthropometric measurements.
A similar meta-analysis of 11 randomized controlled trials found that
people who took EGCG combined with caffeine for 12–13 weeks lost a mean
of 1.31 kg more body weight (or gained 1.31 kg less weight) than those
in control groups [121].
In 2010, the European Food Safety Authority examined health claims
related to green tea and concluded that “a cause and effect relationship
has not been established between the consumption of catechins
(including EGCG) from green tea…and contribution to the maintenance or
achievement of a normal body weight.” [
122].
Taken together, the findings of these studies suggest that if green tea
is an effective weight-loss aid, any effect it has is small and not
likely to be clinically relevant [
119,
120].
Safety: No adverse effects have been reported from the consumption of green tea as a beverage [114].
For green tea extract, most reported adverse effects are mild to
moderate, including nausea, constipation, abdominal discomfort, and
increased blood pressure [
119].
However, consumption of green tea extract—primarily ethanolic extracts
of green tea—has been linked to liver damage in several case reports [
32]. These reports prompted the U.S. Pharmacopeia (USP) to systematically review the safety of green tea products in 2008 [
123].
Using clinical case report data and animal pharmacological and
toxicological information, the USP concluded that the consumption of
green tea products “probably” caused 7 cases of liver damage and
“possibly” caused another 27 cases. The USP noted that problems are more
likely to occur when green tea extract is taken on an empty stomach and
therefore, advises taking green tea extracts with food to minimize the
possible risk of liver damage. Other research indicates that green tea
polyphenols do not elevate liver enzymes or cause liver dysfunction when
consumed by healthy men for 3 weeks at a dose of 714 mg/day [
124]. Liver damage from green tea extracts could be partly due to contaminants in some products [
30], but some researchers advise using dietary supplements containing green tea extract with caution [
114].
Guarana (see section on caffeine above)
Guar gum
Guar gum is a soluble dietary fiber derived from the Indian cluster bean Cyamopsis tetragonolobus [125].
Guar gum is present in certain dietary supplements and is an ingredient
in some food products, especially gluten-free baked goods, because it
helps bind and thicken these products. Like glucomannan, guar gum is
purported to promote weight loss by acting as a bulking agent in the
gut, delaying gastric emptying, increasing feelings of satiety, and,
theoretically, decreasing appetite and food intake [
125].
Efficacy: In a meta-analysis of 20 randomized, double-blind,
placebo-controlled trials that statistically pooled data from 11 trials,
Pittler and colleagues evaluated the effects of guar gum for body
weight reduction in a total of 203 adults [125].
Trial participants included people with hypercholesterolemia,
hyperlipidemia, or type 1 or type 2 diabetes; menopausal women; and
healthy volunteers. Doses of guar gum ranged from 9 to 30 g/day; most
participants followed their usual diet, and some received dietary
advice. Compared with placebo, guar gum had no significant effect on
weight loss. The authors concluded that guar gum is not effective for
body weight reduction.
Safety: Reported adverse effects for guar gum are primarily
gastrointestinal and include abdominal pain, flatulence, diarrhea,
nausea, and cramps [125,
126].
Case reports indicate that guar gum can cause severe esophageal and
small-bowel obstruction if taken without sufficient fluid [
127,
128]. However, these reports were about a guar gum product that is no longer available [
127].
In their meta-analysis, Pittler and colleagues concluded that given the
adverse effects associated with the use of guar gum, the risks of
taking it outweigh its benefits [
125].
Hoodia (Hoodia gordonii)
Hoodia gordonii is a succulent plant that grows in the
Kalahari Desert of southern Africa. The San people have traditionally
used hoodia as an appetite suppressant during long hunts. This anecdotal
evidence, combined with results of a few animal studies indicating that
hoodia reduces food intake [129], led to the widespread marketing of hoodia as a weight-loss supplement in the United States.
Efficacy: Despite its immense popularity as a weight-loss
supplement, very little scientific research on hoodia has been conducted
in humans [130],
and a mechanism of action for its potential weight-loss effects has not
been proposed. In a randomized, controlled trial, 49 healthy overweight
women (mean BMI 25) aged 18–50 years were randomized to receive
Hoodia gordonii
purified extract (2,220 mg/day in two divided doses taken 1 hour before
breakfast and dinner) or placebo combined with an ad libitum diet for
15 days [
131]. Compared to placebo, hoodia extract had no significant effect on energy intake or body weight.
Safety: Hoodia has been reported to cause significant increases in heart rate and blood pressure [131].
It also raises bilirubin and alkaline phosphatase levels (which may
indicate impaired liver function), although the clinical significance of
these findings is unclear because hoodia has not been reported to
affect levels of other liver enzymes. Other side effects include
headache, dizziness, nausea, and vomiting.
Various news reports indicate that some hoodia products contain little or no hoodia [132].
According to a report released in 2007, only 30%–60% of hoodia products
contain adequate amounts of hoodia, although the authors did not
indicate whether “adequate” refers to a therapeutic dose or indicates
that the quantity of hoodia matches the label claim [
133]; more recent data on hoodia content in supplements are not available.
Mate (see section on caffeine above)
Pyruvate
Pyruvate (a derivative of pyruvic acid) is a three-carbon compound that is generated in the body through glycolysis [134].
Pyruvate is also available as a dietary supplement, frequently in the
form of calcium pyruvate. Researchers have suggested that pyruvate
enhances exercise performance and reduces body weight and body fat,
possibly by increasing lipolysis and energy expenditure [
6,
135,
136].
Efficacy: Only a few studies have examined the effects of
pyruvate supplementation in humans. Although some of these studies
suggest that pyruvate decreases body weight and body fat, others do not.
In a double-blind, placebo-controlled trial, 26 overweight men and
women (BMI ≥25) were given 6 g/day pyruvate or placebo for 6 weeks [134].
All participants received counseling to follow a 2,000 kcal/day diet
and completed 45–60 minutes of circuit training 3 times per week. At the
end of the trial, the pyruvate group had significant decreases in body
weight (mean loss of 1.2 kg), body fat, and percent body fat compared to
baseline but no significant changes in lean body mass. In the placebo
group, these measurements did not change significantly compared to
baseline.
Another small study of 14 obese women (BMI 28–53) found that pyruvate
produces greater weight loss and fat loss when isoenergetically
substituted for a glucose placebo for 21 days as part of a low-energy
diet [137].
However, a double-blind, placebo-controlled trial in 23 overweight
women (mean BMI 27.4) who followed their normal diets and participated
in weight training and 30 minutes of walking 3 times per week had a
different outcome [
136].
In this trial, supplementation with 5 g/day calcium pyruvate for 30
days did not significantly affect body weight, body fat, percent body
fat, or lean body mass compared with placebo. The authors of a
systematic review and meta-analysis of 6 randomized controlled trials in
a total of 203 participants concluded that pyruvate (when taken for 3–6
weeks) reduces body weight by a mean of 0.72 kg and body fat by a mean
of 0.54 kg compared to placebo [
135].
However, the authors noted that the methodological quality of all
trials is weak, preventing them from drawing firm conclusions.
Safety: The safety of pyruvate has not been rigorously
studied. Pyruvate causes gas, bloating, diarrhea, and borborygmus
(rumbling noise in intestines resulting from gas) but has no serious
adverse effects when it is administered for up to 6 weeks [134,
135,
137]. Pyruvate might also increase LDL levels and decrease HDL levels [
135,
136]. Additional research is needed to better understand the safety and possible side effects of this compound.
Raspberry ketone
Raspberry ketone is an aromatic compound found in red raspberries
(Rubus idaeus). Its chemical structure has some similarities to those of
capsaicin (present in hot red peppers) and synephrine, compounds whose
effects on obesity and lipid metabolism have been investigated [138].
Raspberry ketone might help prevent weight gain by altering lipid
metabolism. Although it has been touted on the Internet and national
television as an effective way to burn fat, little evidence exists to
support this claim.
Efficacy: Only one randomized controlled trial has examined
the effects of a dietary supplement containing raspberry ketone and
other ingredients. In this trial, 70 overweight men and women aged 21–45
(BMI >27) received daily supplementation with either a placebo or a
weight-loss product, Prograde MetabolismTM (METABO) [139].
This product contained 2,000 mg of a proprietary blend of raspberry
ketone, caffeine, bitter orange, ginger, garlic, cayenne, L-theanine,
and pepper extract along with B- vitamins and chromium. During the
8-week study, participants followed a calorie-restricted diet
(approximately 500 calories less per day than estimated needs) and
engaged in moderate exercise (60 minutes, 3 days per week). Compared to
the placebo group, those receiving METABO lost significantly more body
weight (mean loss of 1.9 kg vs. 0.4 kg for placebo) and fat mass.
However, 25 of the 70 participants dropped out of the study, and results
were reported for only the 45 participants who completed the study
(i.e., the authors did not complete an intention-to-treat analysis).
Furthermore, the product contained many ingredients in addition to
raspberry ketone, making it impossible to determine the effects of
raspberry ketone alone.
Safety: Participants in the METABO study described above had no serious adverse effects [139]. However, additional research on raspberry ketone is needed to more thoroughly understand its safety and side effects.
White kidney bean/bean pod (Phaseolus vulgaris)
White kidney bean or bean pod (Phaseolus vulgaris) is a legume that is native to Mexico, Central America, and South America and is cultivated worldwide [140].
Phaseolus vulgaris
extract is an ingredient in some weight-loss dietary supplements
marketed as carbohydrate- or starch-absorption “blockers.” Laboratory
research indicates that
Phaseolus vulgaris extract inhibits
alpha-amylase activity, so experts have hypothesized that the plant
interferes with the breakdown and absorption of carbohydrates in the
gastrointestinal tract [
140-142].
Phaseolus vulgaris might also act as an appetite suppressant [
140].
Efficacy: The effect of Phaseolus vulgaris on weight
loss and body fat has been examined in a few clinical trials, with
inconsistent results. In a randomized, double-blind, placebo-controlled
trial conducted in Italy, 60 overweight women (weighing 11–33 lb more
than ideal body weight) aged 20–45 followed a 2,000–2,200- calorie meal
plan and took a tablet containing approximately 445 mg dried aqueous
extract of Phaseolus vulgaris (Phase 2® Starch Neutralizer IV) or a placebo once daily before eating a carbohydrate-rich meal [143]. After 30 days, those receiving
Phaseolus vulgaris
extract lost significantly more weight (mean weight loss 2.93 kg) than
those receiving placebo (mean weight loss 0.35 kg). Those in the
Phaseolus vulgaris
group also experienced a significantly greater reduction in fat mass,
adipose tissue thickness, and waist–hip–thigh circumference. However, in
a similar trial conducted in the United States in 39 overweight adults
(mostly women, BMI 30–43) aged 20–69, those who consumed 1,500 mg Phase
2® starch neutralizer twice daily with lunch and dinner (total daily
dose 3,000 mg) for 8 weeks with a high-fiber/low-fat diet did not
experience significantly greater weight loss than those receiving a
placebo [
141].
The authors of a 2011 review of 6 trials (including the 2 trials
described above) with a total of 247 participants concluded that Phaseolus vulgaris significantly reduces body fat (mean difference 1.86 kg compared to placebo) but does not significantly affect weight loss [140].
However, the authors noted that the quality of the trials included in
their review was poor, making it impossible to draw firm conclusions.
After the publication of this review, a 12-week clinical trial in 123 overweight and obese men and women found that Phaseolus vulgaris modestly yet significantly reduced body weight and body fat [144]. Participants consumed either a placebo or 1,000 mg
Phaseolus vulgaris (IQP-PV-101; marketed under Phase 2®, Starchlite®, and Phaselite
TM
brands) 3 times per day before meals for a total daily dose of 3,000 mg
while following a mildly hypocaloric diet (500 kcal/day less than basal
energy needs). Compared to placebo, those receiving
Phaseolus vulgaris
lost significantly more body weight (mean loss of 2.91 kg vs. 0.92 kg
for placebo) and body fat (2.23 kg vs. 0.65 kg for placebo).
Safety: Reported adverse effects for Phaseolus vulgaris are fairly minor and include headaches, soft stools, flatulence, and constipation [140]. No serious adverse effects of
Phaseolus vulgaris have been reported in clinical trials, but no trials have lasted longer than 13 weeks.
Yerba mate (see section on caffeine above)
Yohimbe (Pausinystalia yohimbe, yohimbine)
Yohimbe (Pausinystalia yohimbe, Pausinystalia johimbe)
is a West African evergreen tree. The tree’s bark contains the alkaloid
yohimbine, which is the main active constituent of yohimbe [145]. Yohimbine has hyperadrenergic physiological effects because it acts as an alpha-2 receptor antagonist [
6,
146].
Yohimbe extract is found in some dietary supplements that are promoted
for libido enhancement, body building, and weight loss [
145],
but it is used primarily as a traditional remedy for sexual dysfunction
in men. A form of yohimbine—yohimbine hydrochloride—is a prescription
drug used to treat erectile dysfunction [
145,
147].
Efficacy: Very little research has been conducted on the use
of yohimbe for weight loss and/or its effect on body mass. In a small
clinical trial, yohimbine (5 mg taken 4 times/day) resulted in greater
weight loss (mean weight loss 3.55 kg) than placebo (mean weight loss
2.21 kg) in 20 obese females (mean BMI 40 and 43 for placebo and
yohimbine groups, respectively) who followed a low-energy diet (1,000
kcal/day) for 3 weeks [148].
However, in another clinical trial in 47 men (weighing >20% more
than ideal body weight), high-dose yohimbine (peak dose 43 mg/day) for 6
months had no effect on body weight or body fat compared with placebo [
149].
The authors of a 2011 review of yohimbe concluded that no conclusive
evidence indicates that yohimbe affects body weight or body mass [
146].
The author of a 2010 review of yohimbe reached similar conclusions,
noting that results from small human trials of yohimbine for weight loss
are contradictory and the evidence base is insufficient to support a
weight loss claim for this compound [
145].
Safety: Yohimbe can be dangerous. Taking 20 to 40 mg has been
reported to increase blood pressure slightly, whereas doses of 200 mg or
higher can cause headaches, hypertension, anxiety, agitation,
tachycardia, myocardial infarction, cardiac failure, and death [32,
126,
145,
146,
150]. Although yohimbe is generally well tolerated at low doses [
146],
no safe dose has been established for it. Yohimbe should only be used
under medical supervision because of its potential to produce serious
adverse effects [
150].
Like all dietary supplements, weight-loss supplements can have side
effects and might interact with prescription and over-the-counter
medications. In some cases, the active constituents of botanical or
other ingredients promoted for weight loss are unknown or
uncharacterized [21].
Furthermore, many weight-loss supplements contain multiple ingredients
that have not been adequately tested in combination with one another.
Pittler and Ernst note that for ingredients lacking convincing
evidence of effectiveness, “even minor adverse events shift the delicate
risk-benefits balance against their use” [6].
People need to talk with their health care providers about the use of
weight-loss dietary supplements to understand what is known—and not
known—about these products.
The FDA and FTC warn consumers to beware of fraudulent claims about weight-loss dietary supplements [151,
152].
Messages like “magic diet pill!,” “melt your fat away! ”, and “lose
weight without diet or exercise!” that sound too good to be true usually
are. At best, products with claims like these do not live up to them,
and even worse, they could be dangerous.
Weight-loss products, marketed as dietary supplements, are sometimes
adulterated or tainted with prescription-drug ingredients; controlled
substances; or untested/unstudied, pharmaceutically active ingredients
that could be harmful [153].
Between January 2004 and December 2012, 237 dietary supplements were
subject to a Class I recall by the FDA, meaning there was a reasonable
probability that the use of or exposure to these products would cause
serious adverse health consequences. Of these products, 27% were
weight-loss dietary supplements [154].
In most cases, the recall was due to the presence of undeclared drug
ingredients. In 2013, the FDA issued 30 public notifications warning
consumers not to purchase specific weight-loss products because they
contain a hidden drug ingredient—often sibutramine, a weight-loss
medication that was withdrawn from the U.S. market in 2010 because of
safety concerns [
153].
A product represented as a dietary supplement that contains one or more
drug ingredients, whether or not they are declared on the label, is
considered an unapproved drug and is therefore subject to enforcement
action by the FDA. The FDA maintains a
webpage listing public notifications about tainted weight-loss products.
Some ingredients in weight-loss dietary supplements can interact with
certain medications. For example, glucomannan and guar gum might
decrease the absorption of many drugs that are taken orally [107,
128]. Glucomannan has been reported to lower blood glucose levels [
100] and, therefore, could interact with diabetes medications [
107]. Chitosan might potentiate the anticoagulant effects of warfarin [
155]. Green tea could interact with chemotherapy drugs [
156,
157].
Garcinia cambogia
was associated with serotonin toxicity in a patient taking the
supplement together with two selective serotonin reuptake inhibitor
medications [
158].
Other ingredients, such as caffeine and bitter orange, could have an
additive effect if taken with other stimulants. Bitter orange has also
been shown to inhibit CYP3A4 activity, leading to increased blood levels
of certain drugs, such as cyclosporine and saquinavir [
32].
These are just a few examples of interactions between ingredients of
weight-loss dietary supplements and medications. Individuals taking
dietary supplements and medications on a regular basis should discuss
their use with their health care provider.
As this fact sheet shows, the evidence supporting the use of dietary
supplements to reduce body weight and stimulate weight loss is
inconclusive and unconvincing, and the cost of these products can be
considerable [6,
14,
21,
30].
The best way to lose weight and keep it off is to follow a sensible
approach that incorporates a healthy eating plan, reduced caloric
intake, and moderate physical activity under the guidance of a heath
care provider. For some individuals with a high BMI who have additional
health risks, physicians may prescribe adjunctive treatments, including
FDA-approved prescription medications or bariatric surgery, in addition
to lifestyle modifications [
7].
Lifestyle changes that promote weight loss might also improve mood and
energy levels and lower the risk of heart disease, diabetes, and some
cancers [
5].
The Weight-control Information Network,
a service of the National Institute of Diabetes and Digestive and
Kidney Diseases at the National Institutes of Health, provides several
helpful publications on weight control, obesity, physical activity, and
related nutritional issues.
The federal government’s 2015-2020 Dietary Guidelines for Americans
notes that “Nutritional needs should be met primarily from foods. …
Foods in nutrient-dense forms contain essential vitamins and minerals
and also dietary fiber and other naturally occurring substances that may
have positive health effects. In some cases, fortified foods and
dietary supplements may be useful in providing one or more nutrients
that otherwise may be consumed in less-than-recommended amounts.”
For more information about building a healthy diet, refer to the Dietary Guidelines for Americans and the U.S. Department of Agriculture’s
MyPlate.
The Dietary Guidelines for Americans describes a healthy eating pattern as one that:
- Includes a variety of vegetables, fruits, whole grains, fat-free or low-fat milk and milk products, and oils.
- Includes a variety of protein foods, including seafood, lean meats
and poultry, eggs, legumes (beans and peas), nuts, seeds, and soy
products.
- Limits saturated and trans fats, added sugars, and sodium.
- Stays within your daily calorie needs.
- Flegal KM, Carroll MD, Kit BK, Ogden CL.
Prevalence of obesity and trends in the distribution of body mass index
among US adults, 1999-2010. JAMA 2012;307:491-7. [PubMed abstract]
- Ogden CL, Carroll MD, Kit BK, Flegal KM.
Prevalence of obesity and trends in body mass index among US children
and adolescents, 1999-2010. JAMA 2012;307:483-90. [PubMed abstract]
- Lenz TL, Hamilton WR. Supplemental products used for weight loss. J Am Pharm Assoc (2003) 2004;44:59-67.
[PubMed abstract]
- U.S. Department of Agriculture, U.S. Department of Health and Human Services. Dietary Guidelines for Americans, 2010. 7th ed. Washington, DC: U.S. Government Printing Office; 2010.
-
- Pittler MH, Ernst E. Dietary supplements for body-weight reduction: a systematic review. Am J Clin Nutr 2004;79:529-36.
[PubMed abstract]
- Jensen MD, Ryan DH, Apovian CM, Ard JD,
Comuzzie AG, Donato KA, et al. 2013 AHA/ACC/TOS guideline for the
management of overweight and obesity in adults: a report of the American
College of Cardiology/American Heart Association Task Force on Practice
Guidelines and The Obesity Society. Circulation 2014;129:S102-38.
[PubMed abstract]
- Blanck HM, Serdula MK, Gillespie C,
Galuska DA, Sharpe PA, Conway JM, et al. Use of nonprescription dietary
supplements for weight loss is common among Americans. J Am Diet Assoc
2007;107:441-7.
[PubMed abstract]
-
- Bailey RL, Gahche JJ, Miller PE, Thomas PR, Dwyer JT. Why US adults use dietary supplements. JAMA Intern Med 2013;173:355-61.
[PubMed abstract]
- Sharpe PA, Granner ML, Conway JM,
Ainsworth BE, Dobre M. Availability of weight-loss supplements: Results
of an audit of retail outlets in a southeastern city. J Am Diet Assoc
2006;106:2045-51.
[PubMed abstract]
-
-
- Astell KJ, Mathai ML, Su XQ. Plant
extracts with appetite suppressing properties for body weight control: a
systematic review of double blind randomized controlled clinical
trials. Complement Ther Med 2013;21:407-16.
[PubMed abstract]
- Allison DB, Fontaine KR, Heshka S,
Mentore JL, Heymsfield SB. Alternative treatments for weight loss: a
critical review. Crit Rev Food Sci Nutr 2001;41:1-28; discussion 39-40.
[PubMed abstract]
- Haaz S, Fontaine KR, Cutter G, Limdi N,
Perumean-Chaney S, Allison DB. Citrus aurantium and synephrine
alkaloids in the treatment of overweight and obesity: an update. Obes
Rev 2006;7:79-88.
[PubMed abstract]
- Seifert JG, Nelson A, Devonish J, Burke
ER, Stohs SJ. Effect of acute administration of an herbal preparation
on blood pressure and heart rate in humans. Int J Med Sci 2011;8:192-7. [PubMed abstract]
- Stohs SJ, Preuss HG, Shara M. The safety of Citrus aurantium (bitter orange) and its primary protoalkaloid p-synephrine. Phytother Res 2011;25:1421-8.
[PubMed abstract]
- Roman MC, Betz JM, Hildreth J.
Determination of synephrine in bitter orange raw materials, extracts,
and dietary supplements by liquid chromatography with ultraviolet
detection: single-laboratory validation. J AOAC Int 2007;90:68-81.
[PubMed abstract]
- Stohs SJ, Preuss HG, Shara M. A review of the human clinical studies involving Citrus aurantium (bitter orange) extract and its primary protoalkaloid p-synephrine. Int J Med Sci 2012;9:527-38.
[PubMed abstract]
- Dwyer JT, Allison DB, Coates PM. Dietary supplements in weight reduction. J Am Diet Assoc 2005;105:S80-6. [PubMed abstract]
-
- Bent S, Padula A, Neuhaus J. Safety and efficacy of Citrus aurantium for weight loss. Am J Cardiol 2004;94:1359-61.
[PubMed abstract]
- Greenway F, de Jonge-Levitan L, Martin
C, Roberts A, Grundy I, Parker C. Dietary herbal supplements with
phenylephrine for weight loss. J Med Food 2006;9:572-8.
[PubMed abstract]
-
- Kaats GR, Miller H, Preuss HG, Stohs SJ. A 60day double-blind, placebo-controlled safety study involving Citrus aurantium (bitter orange) extract. Food Chem Toxicol 2013;55:358-62.
[PubMed abstract]
- Haller CA, Benowitz NL, Jacob P, 3rd.
Hemodynamic effects of ephedra-free weight-loss supplements in humans.
Am J Med 2005;118:998-1003.
[PubMed abstract]
- Bui LT, Nguyen DT, Ambrose PJ. Blood
pressure and heart rate effects following a single dose of bitter
orange. Ann Pharmacother 2006;40:53-7. [PubMed abstract]
- Hansen DK, George NI, White GE,
Pellicore LS, Abdel-Rahman A, Fabricant D, et al. Physiological effects
following administration of Citrus aurantium for 28 days in rats. Toxicol Appl Pharmacol 2012;261:236-47.
[PubMed abstract]
- Manore MM. Dietary supplements for
improving body composition and reducing body weight: where is the
evidence? Int J Sport Nutr Exerc Metab 2012;22:139-54.
[PubMed abstract]
- Yen M, Ewald MB. Toxicity of weight loss agents. J Med Toxicol 2012;8:145-52.
[PubMed abstract]
-
- Astrup A, Toubro S, Cannon S, Hein P,
Breum L, Madsen J. Caffeine: a double-blind, placebo-controlled study of
its thermogenic, metabolic, and cardiovascular effects in healthy
volunteers. Am J Clin Nutr 1990;51:759-67.
[PubMed abstract]
- Boozer CN, Daly PA, Homel P, Solomon
JL, Blanchard D, Nasser JA, et al. Herbal ephedra/caffeine for weight
loss: a 6-month randomized safety and efficacy trial. Int J Obes Relat
Metab Disord 2002;26:593-604.
[PubMed abstract]
- Andersen T, Fogh J. Weight loss and
delayed gastric emptying following a South American herbal preparation
in overweight patients. J Hum Nutr Diet 2001;14:243-50.
[PubMed abstract]
- Lopez-Garcia E, van Dam RM, Rajpathak
S, Willett WC, Manson JE, Hu FB. Changes in caffeine intake and
long-term weight change in men and women. Am J Clin Nutr 2006;83:674-80.
[PubMed abstract]
-
- Torpy JM, Livingston EH. JAMA patient page. Energy drinks. JAMA 2013;309:297.
[PubMed abstract]
- Committee to Review Dietary Reference
Intakes for Vitamin D and Calcium, Food and Nutrition Board, Institute
of Medicine. In: Ross AC, Taylor CL, Yaktine AL, Del Valle HB, eds.
Dietary Reference Intakes for Calcium and Vitamin D. Washington (DC);
2011. [PubMed abstract]
- Davies KM, Heaney RP, Recker RR, Lappe
JM, Barger-Lux MJ, Rafferty K, et al. Calcium intake and body weight. J
Clin Endocrinol Metab 2000;85:4635-8.
[PubMed abstract]
- Heaney RP. Normalizing calcium intake: projected population effects for body weight. J Nutr 2003;133:268S-70S.
[PubMed abstract]
- Parikh SJ, Yanovski JA. Calcium intake and adiposity. Am J Clin Nutr 2003;77:281-7.
[PubMed abstract]
- Zemel MB, Shi H, Greer B, Dirienzo D, Zemel PC. Regulation of adiposity by dietary calcium. FASEB J 2000;14:1132-8.
[PubMed abstract]
- Jacobsen R, Lorenzen JK, Toubro S,
Krog-Mikkelsen I, Astrup A. Effect of short-term high dietary calcium
intake on 24-h energy expenditure, fat oxidation, and fecal fat
excretion. Int J Obes (Lond) 2005;29:292-301.
[PubMed abstract]
- Christensen R, Lorenzen JK, Svith CR,
Bartels EM, Melanson EL, Saris WH, et al. Effect of calcium from dairy
and dietary supplements on faecal fat excretion: a meta-analysis of
randomized controlled trials. Obes Rev 2009;10:475-86.
[PubMed abstract]
- Heaney RP, Davies KM, Barger-Lux MJ. Calcium and weight: clinical studies. J Am Coll Nutr 2002;21:152S-5S.
[PubMed abstract]
- Shi H, Dirienzo D, Zemel MB. Effects of
dietary calcium on adipocyte lipid metabolism and body weight
regulation in energy-restricted aP2-agouti transgenic mice. FASEB J
2001;15:291-3.
[PubMed abstract]
- Zemel MB, Richards J, Mathis S,
Milstead A, Gebhardt L, Silva E. Dairy augmentation of total and central
fat loss in obese subjects. Int J Obes (Lond) 2005;29:391-7.
[PubMed abstract]
- Zemel MB, Richards J, Milstead A,
Campbell P. Effects of calcium and dairy on body composition and weight
loss in African-American adults. Obes Res 2005;13:1218-25.
[PubMed abstract]
- Zemel MB, Thompson W, Milstead A,
Morris K, Campbell P. Calcium and dairy acceleration of weight and fat
loss during energy restriction in obese adults. Obes Res 2004;12:582-90.
[PubMed abstract]
- Yanovski JA, Parikh SJ, Yanoff LB,
Denkinger BI, Calis KA, Reynolds JC, et al. Effects of calcium
supplementation on body weight and adiposity in overweight and obese
adults: a randomized trial. Ann Intern Med 2009;150:821-9, W145-6.
[PubMed abstract]
- Chung M, Balk EM, Brendel M, Ip S, Lau
J, Lee J, et al. Vitamin D and calcium: a systematic review of health
outcomes. Evid Rep Technol Assess (Full Rep) 2009:1-420.
[PubMed abstract]
- Chen M, Pan A, Malik VS, Hu FB. Effects
of dairy intake on body weight and fat: a meta-analysis of randomized
controlled trials. Am J Clin Nutr 2012;96:735-47.
[PubMed abstract]
- Trowman R, Dumville JC, Hahn S,
Torgerson DJ. A systematic review of the effects of calcium
supplementation on body weight. Br J Nutr 2006;95:1033-8.
[PubMed abstract]
- Curhan GC, Willett WC, Rimm EB,
Stampfer MJ. A prospective study of dietary calcium and other nutrients
and the risk of symptomatic kidney stones. N Engl J Med 1993;328:833-8.
[PubMed abstract]
- Curhan GC, Willett WC, Speizer FE,
Spiegelman D, Stampfer MJ. Comparison of dietary calcium with
supplemental calcium and other nutrients as factors affecting the risk
for kidney stones in women. Ann Intern Med 1997;126:497-504.
[PubMed abstract]
- Jackson RD, LaCroix AZ, Gass M, Wallace
RB, Robbins J, Lewis CE, et al. Calcium plus vitamin D supplementation
and the risk of fractures. N Engl J Med 2006;354:669-83.
[PubMed abstract]
- Gades MD, Stern JS. Chitosan supplementation and fat absorption in men and women. J Am Diet Assoc 2005;105:72-7.
[PubMed abstract]
-
- Pittler MH, Abbot NC, Harkness EF,
Ernst E. Randomized, double-blind trial of chitosan for body weight
reduction. Eur J Clin Nutr 1999;53:379-81.
[PubMed abstract]
-
-
- Institute of Medicine, Food and Nutrition Board. Dietary
Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium,
Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium,
and Zinc. Washington, DC: National Academy Press; 2001.
- Onakpoya I, Posadzki P, Ernst E.
Chromium supplementation in overweight and obesity: a systematic review
and meta-analysis of randomized clinical trials. Obes Rev
2013;14:496-507. [PubMed abstract]
- Tian H, Guo X, Wang X, He Z, Sun R, Ge
S, et al. Chromium picolinate supplementation for overweight or obese
adults. Cochrane Database Syst Rev 2013;11:CD010063.
[PubMed abstract]
- Anton SD, Morrison CD, Cefalu WT,
Martin CK, Coulon S, Geiselman P, et al. Effects of chromium picolinate
on food intake and satiety. Diabetes Technol Ther 2008;10:405-12.
[PubMed abstract]
- Pittler MH, Stevinson C, Ernst E.
Chromium picolinate for reducing body weight: meta-analysis of
randomized trials. Int J Obes Relat Metab Disord 2003;27:522-9.
[PubMed abstract]
- Astell KJ, Mathai ML, Su XQ. A review
on botanical species and chemical compounds with appetite suppressing
properties for body weight control. Plant Foods Hum Nutr 2013;68:213-21.
[PubMed abstract]
- Godard MP, Johnson BA, Richmond SR.
Body composition and hormonal adaptations associated with forskolin
consumption in overweight and obese men. Obes Res 2005;13:1335-43.
[PubMed abstract]
- Henderson S, Magu B, Rasmussen C,
Lancaster S, Kerksick C, Smith P, et al. Effects of Coleus forskohlii
supplementation on body composition and hematological profiles in mildly
overweight women. J Int Soc Sports Nutr 2005;2:54-62.
[PubMed abstract]
- Gaullier JM, Halse J, Hoye K,
Kristiansen K, Fagertun H, Vik H, et al. Conjugated linoleic acid
supplementation for 1 y reduces body fat mass in healthy overweight
humans. Am J Clin Nutr 2004;79:1118-25.
[PubMed abstract]
- Egras AM, Hamilton WR, Lenz TL,
Monaghan MS. An evidence-based review of fat modifying supplemental
weight loss products. J Obes 2011;2011.
[PubMed abstract]
- Onakpoya IJ, Posadzki PP, Watson LK,
Davies LA, Ernst E. The efficacy of long-term conjugated linoleic acid
(CLA) supplementation on body composition in overweight and obese
individuals: a systematic review and meta-analysis of randomized
clinical trials. Eur J Nutr 2012;51:127-34.
[PubMed abstract]
- Norris LE, Collene AL, Asp ML, Hsu JC,
Liu LF, Richardson JR, et al. Comparison of dietary conjugated linoleic
acid with safflower oil on body composition in obese postmenopausal
women with type 2 diabetes mellitus. Am J Clin Nutr 2009;90:468-76.
[PubMed abstract]
- Gaullier JM, Halse J, Hoye K,
Kristiansen K, Fagertun H, Vik H, et al. Supplementation with conjugated
linoleic acid for 24 months is well tolerated by and reduces body fat
mass in healthy, overweight humans. J Nutr 2005;135:778-84.
[PubMed abstract]
- Steck SE, Chalecki AM, Miller P, Conway
J, Austin GL, Hardin JW, et al. Conjugated linoleic acid
supplementation for twelve weeks increases lean body mass in obese
humans. J Nutr 2007;137:1188-93.
[PubMed abstract]
- Salas-Salvado J, Marquez-Sandoval F,
Bullo M. Conjugated linoleic acid intake in humans: a systematic review
focusing on its effect on body composition, glucose, and lipid
metabolism. Crit Rev Food Sci Nutr 2006;46:479-88.
[PubMed abstract]
- Terpstra AH. Effect of conjugated
linoleic acid on body composition and plasma lipids in humans: an
overview of the literature. Am J Clin Nutr 2004;79:352-61.
[PubMed abstract]
- Silveira MB, Carraro R, Monereo S, Tebar J. Conjugated linoleic acid (CLA) and obesity. Public Health Nutr 2007;10:1181-6.
[PubMed abstract]
- Riserus U, Arner P, Brismar K, Vessby
B. Treatment with dietary trans10cis12 conjugated linoleic acid causes
isomer-specific insulin resistance in obese men with the metabolic
syndrome. Diabetes Care 2002;25:1516-21.
[PubMed abstract]
-
- Karch SB, Stephens BG. Toxicology and pathology of deaths related to methadone: retrospective review. West J Med 2000;172:11-4.
[PubMed abstract]
-
-
-
- Astrup A, Toubro S, Christensen NJ, Quaade F. Pharmacology of thermogenic drugs. Am J Clin Nutr 1992;55:246S-8S.
[PubMed abstract]
- Shekelle PG, Hardy ML, Morton SC,
Maglione M, Mojica WA, Suttorp MJ, et al. Efficacy and safety of ephedra
and ephedrine for weight loss and athletic performance: a
meta-analysis. JAMA 2003;289:1537-45.
[PubMed abstract]
- Haller CA, Benowitz NL. Adverse
cardiovascular and central nervous system events associated with dietary
supplements containing ephedra alkaloids. N Engl J Med 2000;343:1833-8.
[PubMed abstract]
-
- Jeukendrup AE, Randell R. Fat burners: nutrition supplements that increase fat metabolism. Obes Rev 2011;12:841-51. [PubMed abstract]
- Peng J, Yuan JP, Wu CF, Wang JH.
Fucoxanthin, a marine carotenoid present in brown seaweeds and diatoms:
metabolism and bioactivities relevant to human health. Mar Drugs
2011;9:1806-28. [PubMed abstract]
- Abidov M, Ramazanov Z, Seifulla R,
Grachev S. The effects of Xanthigen in the weight management of obese
premenopausal women with non-alcoholic fatty liver disease and normal
liver fat. Diabetes Obes Metab 2010;12:72-81.
[PubMed abstract]
- Marquez F, Babio N, Bullo M,
Salas-Salvado J. Evaluation of the safety and efficacy of hydroxycitric
acid or Garcinia cambogia extracts in humans. Crit Rev Food Sci Nutr
2012;52:585-94.
[PubMed abstract]
- Saper RB, Eisenberg DM, Phillips RS. Common dietary supplements for weight loss. Am Fam Physician 2004;70:1731-8.
[PubMed abstract]
- Onakpoya I, Hung SK, Perry R, Wider B,
Ernst E. The use of garcinia extract (hydroxycitric acid) as a weight
loss supplement: a systematic review and meta-analysis of randomised
clinical trials. J Obes 2011;2011:509038.
[PubMed abstract]
- Mattes RD, Bormann L. Effects of (-)-hydroxycitric acid on appetitive variables. Physiol Behav 2000;71:87-94.
[PubMed abstract]
- Heymsfield SB, Allison DB, Vasselli JR, Pietrobelli A, Greenfield D, Nunez C. Garcinia cambogia (hydroxycitric acid) as a potential antiobesity agent: a randomized controlled trial. JAMA 1998;280:1596-600.
[PubMed abstract]
- Chuah LO, Ho WY, Beh BK, Yeap SK. Updates on antiobesity effect of Garcinia Origin (-)-HCA. Evid Based Complement Alternat Med 2013;2013:751658.
[PubMed abstract]
- Henry DA, Mitchell AS, Aylward J, Fung
MT, McEwen J, Rohan A. Glucomannan and risk of oesophageal obstruction.
Br Med J (Clin Res Ed) 1986;292:591-2.
[PubMed abstract]
- Sood N, Baker WL, Coleman CI. Effect
of glucomannan on plasma lipid and glucose concentrations, body weight,
and blood pressure: systematic review and meta-analysis. Am J Clin Nutr
2008;88:1167-75.
[PubMed abstract]
- Vido L, Facchin P, Antonello I, Gobber
D, Rigon F. Childhood obesity treatment: double blinded trial on
dietary fibres (glucomannan) versus placebo. Padiatr Padol
1993;28:133-6.
[PubMed abstract]
- Walsh DE, Yaghoubian V, Behforooz A. Effect of glucomannan on obese patients: a clinical study. Int J Obes 1984;8:289-93.
[PubMed abstract]
- Arvill A, Bodin L. Effect of
short-term ingestion of konjac glucomannan on serum cholesterol in
healthy men. Am J Clin Nutr 1995;61:585-9.
[PubMed abstract]
- Zalewski BM, Chmielewska A, Szajewska
H. The effect of glucomannan on body weight in overweight or obese
children and adults: A systematic review of randomized controlled
trials. Nutrition 2015 31:437-442. [PubMed abstract]
- Zalewski BM, Chmielewska A, Szajewska
H, Keithley JK, Li P, Goldsby TU, Allison DB. Correction of data errors
and reanalysis of “The effect of glucomannan on body weight in
overweight or obese children and adults: A systematic review of
randomized controlled trials”. Nutrition 2015;31:1056-7. [PubMed abstract]
- Onakpoya I, Posadzki P, Ernst E. The
efficacy of glucomannan supplementation in overweight and obesity: a
systematic review and meta-analysis of randomized clinical trials. J Am
Coll Nutr 2014;33:70-8.
[PubMed abstract]
-
- Farah A, Monteiro M, Donangelo CM,
Lafay S. Chlorogenic acids from green coffee extract are highly
bioavailable in humans. J Nutr 2008;138:2309-15.
[PubMed abstract]
-
[PubMed abstract]
-
- Vinson JA, Burnham BR, Nagendran MV.
Randomized, double-blind, placebo-controlled, linear dose, crossover
study to evaluate the efficacy and safety of a green coffee bean extract
in overweight subjects. Diabetes Metab Syndr Obes 2012;5:21-7.
[PubMed abstract]
- Federal Trade Commission. FTC Charges Green Coffee Bean Sellers with Deceiving Consumers through Fake News Sites and Bogus Weigh Loss Claims. Federal Trade Commission, 2014.
-
- Grove KA, Lambert JD. Laboratory, epidemiological, and human intervention studies show that tea (Camellia sinensis) may be useful in the prevention of obesity. J Nutr 2010;140:446-53.
[PubMed abstract]
- Hursel R, Westerterp-Plantenga MS.
Catechin- and caffeine-rich teas for control of body weight in humans.
Am J Clin Nutr 2013;98:1682S-93S.
[PubMed abstract]
- Rains TM, Agarwal S, Maki KC. Antiobesity effects of green tea catechins: a mechanistic review. J Nutr Biochem 2011;22:1-7.
[PubMed abstract]
- Lonac MC, Richards JC, Schweder MM,
Johnson TK, Bell C. Influence of short-term consumption of the
caffeine-free, epigallocatechin-3-gallate supplement, Teavigo, on
resting metabolism and the thermic effect of feeding. Obesity (Silver
Spring) 2011;19:298-304.
[PubMed abstract]
- Mielgo-Ayuso J, Barrenechea L, Alcorta
P, Larrarte E, Margareto J, Labayen I. Effects of dietary
supplementation with epigallocatechin-3-gallate on weight loss, energy
homeostasis, cardiometabolic risk factors and liver function in obese
women: randomised, double-blind, placebo-controlled clinical trial. Br J
Nutr 2014;111:1263-71.
[PubMed abstract]
- Jurgens TM, Whelan AM, Killian L,
Doucette S, Kirk S, Foy E. Green tea for weight loss and weight
maintenance in overweight or obese adults. Cochrane Database Syst Rev
2012;12:CD008650.
[PubMed abstract]
- Phung OJ, Baker WL, Matthews LJ,
Lanosa M, Thorne A, Coleman CI. Effect of green tea catechins with or
without caffeine on anthropometric measures: a systematic review and
meta-analysis. Am J Clin Nutr 2010;91:73-81.
[PubMed abstract]
- Hursel R, Viechtbauer W,
Westerterp-Plantenga MS. The effects of green tea on weight loss and
weight maintenance: a meta-analysis. Int J Obes (Lond) 2009;33:956-61. [PubMed abstract]
EFSA
Panel on Dietetic Products, Nutrition and Allergies (NDA). Scientific
opinion on the substantiation of health claims related to Camellia sinensis (L.)
kuntze (tea), including catechins from green tea, and contribution to
the maintenance or achievement of a normal body weight (ID 1107, 1112,
1544, 2716), increased beta-oxidation of fatty acids leading to a
reduction in body fat mass (ID 1123, 1124, 3698), and maintenance of
normal blood glucose concentrations (ID 1115, 1545) pursuant to Article
13(1) of Regulation (EC) No 1924/2006. EFSA Journal 2010;8:1791-812.
- Sarma DN, Barrett ML, Chavez ML,
Gardiner P, Ko R, Mahady GB, et al. Safety of green tea extracts : a
systematic review by the US Pharmacopeia. Drug Saf 2008;31:469-84.
[PubMed abstract]
- Frank J, George TW, Lodge JK,
Rodriguez-Mateos AM, Spencer JP, Minihane AM, et al. Daily consumption
of an aqueous green tea extract supplement does not impair liver
function or alter cardiovascular disease risk biomarkers in healthy men.
J Nutr 2009;139:58-62.
[PubMed abstract]
- Pittler MH, Ernst E. Guar gum for body weight reduction: meta-analysis of randomized trials. Am J Med 2001;110:724-30.
[PubMed abstract]
- Pittler MH, Schmidt K, Ernst E.
Adverse events of herbal food supplements for body weight reduction:
systematic review. Obes Rev 2005;6:93-111.
[PubMed abstract]
- Lewis JH. Esophageal and small bowel
obstruction from guar gum-containing “diet pills”: analysis of 26 cases
reported to the Food and Drug Administration. Am J Gastroenterol
1992;87:1424-8.
[PubMed abstract]
-
- an Heerden FR, Marthinus Horak R, Maharaj VJ, Vleggaar R, Senabe JV, Gunning PJ. An appetite suppressant from Hoodia species. Phytochemistry 2007;68:2545-53.
[PubMed abstract]
- Whelan AM, Jurgens TM, Szeto V. Case
report. Efficacy of hoodia for weight loss: is there evidence to support
the efficacy claims? J Clin Pharm Ther 2010;35:609-12.
[PubMed abstract]
- Blom WA, Abrahamse SL, Bradford R, Duchateau GS, Theis W, Orsi A, et al. Effects of 15-d repeated consumption of Hoodia gordonii purified
extract on safety, ad libitum energy intake, and body weight in
healthy, overweight women: a randomized controlled trial. Am J Clin Nutr
2011;94:1171-81.
[PubMed abstract]
-
- Lee RA, Balick MJ. Indigenous use of Hoodia gordonii and appetite suppression. Explore (NY) 2007;3:404-6.
[PubMed abstract]
- Kalman D, Colker CM, Wilets I, Roufs
JB, Antonio J. The effects of pyruvate supplementation on body
composition in overweight individuals. Nutrition 1999;15:337-40.
[PubMed abstract]
- Onakpoya I, Hunt K, Wider B, Ernst E.
Pyruvate supplementation for weight loss: a systematic review and
meta-analysis of randomized clinical trials. Crit Rev Food Sci Nutr
2014;54:17-23.
[PubMed abstract]
- Koh-Banerjee PK, Ferreira MP,
Greenwood M, Bowden RG, Cowan PN, Almada AL, et al. Effects of calcium
pyruvate supplementation during training on body composition, exercise
capacity, and metabolic responses to exercise. Nutrition 2005;21:312-9. [PubMed abstract]
- Stanko RT, Tietze DL, Arch JE. Body
composition, energy utilization, and nitrogen metabolism with a
4.25-MJ/d low-energy diet supplemented with pyruvate. Am J Clin Nutr
1992;56:630-5. [PubMed abstract]
- Morimoto C, Satoh Y, Hara M, Inoue S, Tsujita T, Okuda H. Anti-obese action of raspberry ketone. Life Sci 2005;77:194-204. [PubMed abstract]
- Lopez HL, Ziegenfuss TN, Hofheins JE,
Habowski SM, Arent SM, Weir JP, et al. Eight weeks of supplementation
with a multi-ingredient weight loss product enhances body composition,
reduces hip and waist girth, and increases energy levels in overweight
men and women. J Int Soc Sports Nutr 2013;10:22. [PubMed abstract]
- Onakpoya I, Aldaas S, Terry R, Ernst E. The efficacy of Phaseolus vulgaris as a weight-loss supplement: a systematic review and meta-analysis of randomised clinical trials. Br J Nutr 2011;106:196-202.
[PubMed abstract]
- Udani J, Hardy M, Madsen DC. Blocking
carbohydrate absorption and weight loss: a clinical trial using Phase 2
brand proprietary fractionated white bean extract. Altern Med Rev
2004;9:63-9.
[PubMed abstract]
- Obiro WC, Zhang T, Jiang B. The nutraceutical role of the Phaseolus vulgaris alpha-amylase inhibitor. Br J Nutr 2008;100:1-12. [PubMed abstract]
- Celleno L, Tolaini MV, D’Amore A, Perricone NV, Preuss HG. A dietary supplement containing standardized Phaseolus vulgaris extract influences body composition of overweight men and women. Int J Med Sci 2007;4:45-52.
[PubMed abstract]
- Grube B, Chong WF, Chong PW, Riede L.
Weight reduction and maintenance with IQP-PV-101: a 12-week randomized
controlled study with a 24-week open label period. Obesity
2014;22:645-51. [PubMed abstract]
-
- Cimolai N, Cimolai T. Yohimbine use for physical enhancement and its potential toxicity. J Diet Suppl 2011;8:346-54.
[PubMed abstract]
-
- Kucio C, Jonderko K, Piskorska D. Does yohimbine act as a slimming drug? Isr J Med Sci 1991;27:550-6.
[PubMed abstract]
- Sax L. Yohimbine does not affect fat distribution in men. Int J Obes 1991;15:561-5.
[PubMed abstract]
-
-
-
- U.S. Food and Drug Administration. Tainted Weight Loss Products. 2014.
- Harel Z, Harel S, Wald R, Mamdani M,
Bell CM. The frequency and characteristics of dietary supplement recalls
in the United States. JAMA Intern Med 2013;173:926-8.
[PubMed abstract]
- Huang SS, Sung SH, Chiang CE. Chitosan potentiation of warfarin effect. Ann Pharmacother 2007;41:1912-4.
[PubMed abstract]
-
- Shin SC, Choi JS. Effects of
epigallocatechin gallate on the oral bioavailability and
pharmacokinetics of tamoxifen and its main metabolite,
4-hydroxytamoxifen, in rats. Anticancer Drugs 2009;20:584-8.
[PubMed abstract]
- Lopez AM, Kornegay J, Hendrickson RG. Serotonin toxicity associated with Garcinia cambogia over-the-counter supplement. J Med Toxicol 2014. [PubMed abstract]
Комментариев нет:
Отправить комментарий